mRNA treatments could help stop cancer recurrence: Study

Researchers are particularly encouraged by new data involving a personalized mRNA therapy developed by Moderna and Merck.

Invivyd doses first participants in Phase 3 COVID-19 trial

Invivyd Inc (NASDAQ:IVVD) has dosed the first participants in its LIBERTY Phase 3 trial, a study testing the company's ...

Cancer vaccines based on mRNA advance, despite US cuts

By Julie Steenhuysen CHICAGO, June 9 (Reuters) - Treatments based on the same mRNA technology that delivered COVID-19 ...

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to ...

LIBERTY clinical trial will evaluate the comparative safety and tolerability of VYD2311 versus mRNA COVID-19 vaccine, as well as explore the ...
Medical Xpress

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we ...

A cancer vaccine made just for you. mRNA is back and it's fighting melanoma

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

Pfizer didn't say hantavirus is side effect of its COVID-19 vaccine, contrary to online claims

Those eager to discredit Pfizer's mRNA vaccine, which is safe and effective, exploited the cruise ship outbreak.
Forbes

How mRNA Vaccine Platform Suffers Mainly From Manufactured Distrust

WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...